Arix Bioscience Investor Relations Material

Arix Bioscience PLC is a global venture capital company investing in biotechnology companies. It focuses on cutting-edge advances in life sciences, aiming to accelerate the development of new treatments for patients. Arix Bioscience works closely with exceptional entrepreneurs, providing not only capital but also expertise and access to global networks. The company has a diversified investment portfolio that includes companies working on therapies for oncology, orphan diseases, infectious diseases, and gene therapies. Arix Bioscience's model is to source, finance, and develop these innovative technologies, taking an active role in their portfolio companies by often taking board seats to support growth and clinical success. Arix Bioscience is headquartered in London, UK, and its shares are listed on the London Stock Exchange.